The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Rapid Growth and Projected Expansion

• Market size surged from $19.77 billion in 2023 to $22.1 billion in 2024 at a CAGR of 11.8%.
• Expected to reach $32.44 billion by 2028, growing at a CAGR of 10.1%.
• Historic and forecast growth attributed to several factors.

Drivers of Growth

• Increasing prevalence of infectious diseases.
• Strong economic growth in emerging markets.
• Technological advances.
• Rising demand for personalized medicines.

Fueling Demand: Growing Cancer Incidence Rates

• Cancer, including lung, prostate, bowel, and female breast cancer, constitutes 43% of all new cancer cases worldwide.
• Anticipated rise in cancer incidence rates globally.
• Expected boost in demand for anatomic pathology equipment and consumables.

Read More On The Anatomic Pathology Equipment and Consumables Market Report 2024 – https://www.thebusinessresearchcompany.com/report/anatomic-pathology-equipment-and-consumables-global-market-report

Key Players in the Market

• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• NeoGenomics Laboratories Inc.
• BioGenex Laboratories
• Sakura Finetek USA Inc.
• Shimadzu Corporation
• Bionics Scientific Technologies (P) Ltd.
• ACMAS Technologies Pvt. Ltd.
• Labindia Instruments Pvt. Ltd.
• Hospital Supply Company Pvt. Ltd.
• Somatco
• ANDAAF Scientific Ltd.
• Katchey Company Limited.

Technological Advancements Driving Efficiency

• Investment in new technologies for better efficiency and reduced testing time.
• Example: Biogenex’s automated staining technology – Xmatrx and i6000 diagnostics.
• Matrix systems offer standardized processes and prevent cross-contamination.
• i6000 diagnostics boasts a staining capacity of 200 slides in 8 hours.

Strategic Acquisition: Epredia Expands Portfolio

• US-based cancer diagnostics company Epredia acquired MMFrance and Laurypath in September 2022.
• Acquisition aligns with the company’s strategy to expand its cancer diagnostics business.
• MMFrance and Laurypath are French anatomical pathology product manufacturers established in 1987.

Market Segmentation

1. By Products and Services
   • Instruments
   • Consumables
   • Services
2. By Application
   • Cancer
   • Other Diseases
   • Research
3. By End-Use
   • Hospital
   • Clinical Laboratories
   • Research

Regional Dominance

• North America led the anatomical pathology equipment and consumables market in 2023.

In conclusion, the anatomic pathology equipment and consumables market is witnessing substantial growth driven by various factors including technological advancements, rising cancer incidence rates, and strategic expansions by key players. With the increasing demand for personalized medicines and the growth of pathology training programs, the market is poised for further expansion in the coming years. Innovations in AI and 3D printing are expected to shape the future landscape of this dynamic industry.

Request for A Sample Of The Global Anatomic Pathology Equipment and Consumables Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=3410&type=smp